Raynham-Taunton Pediatrics

CLIA Laboratory Citation Details

4
Total Citations
29
Total Deficiencyies
12
Unique D-Tags
CMS Certification Number 22D0978515
Address 876 Broadway, Raynham, MA, 02767
City Raynham
State MA
Zip Code02767
Phone508 824-9500
Lab DirectorMODAR SUKKARIEH

Citation History (4 surveys)

Survey - October 7, 2024

Survey Type: Standard

Survey Event ID: N7X011

Deficiency Tags: D2007 D2009 D6051 D2007 D2009 D6051

Summary:

Summary Statement of Deficiencies D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on American Proficiency Institute (API) record review and interview with the Technical Consultant (TC) the laboratory failed to ensure proficiency testing (PT) was rotated amongst all testing personnel (TP) in the specialty of Microbiology. Finding include: 1. Record review on 10/4/2024 of the laboratory's 2023 and 2024 API Microbiology PT records revealed, one of two TP (TP2) did not run PT samples in 2023 or 2024. 2. Record review on 10/4/2024 of the laboratory's 2023 and 2024 competency records for TP2, revealed: a. The section referring to PT performance was checked off as completed. b. The competency records were signed by the TC. 3. Record review on 10/4/2024 of the laboratory's PT policy revealed, "It is important that each testing person actively participate in the PT program." 4. Staff interview on 10/4/2024 at 11:00 AM with the TC confirmed TP2 did not participate in PT in 2023 and 2024, yet it was marked as completed on TP2's 2023 and 2024 competency form. 5. The laboratory performs 3,000 tests annually in the specialty of Microbiology. D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on American Proficiency Institute (API) proficiency testing (PT) record review and interview with the Technical Consultant (TC), the laboratory failed to ensure attestation sheets were signed by testing personnel (TP) in the specialty of Microbiology. Findings include: 1. Record review on 10/4/2024 of the laboratory's 2023 API Microbiology PT records revealed, the laboratory did not have a copy of the attestation sheet signed by the analyst and for the 2023 supplemental Microbiology event. 2. Record review on 10/4/2024 of the laboratory's PT policy revealed, "The person performing the test signs the form in the indicated area." "The signed PT attestation sheets must be kept for 2 years." 3. Interview with the TC on 10/4/2024 at 11:00 AM confirmed the above findings. TC stated, "API did not provide one for this survey." 4. The laboratory performs 3,000 tests annually in the specialty of Microbiology. D6051 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(8)(v) The procedures for evaluation of the competency of the staff must include, but are not limited to assessment of test performance through testing previously analyzed specimens, internal blind testing samples or external proficiency testing samples. This STANDARD is not met as evidenced by: Based on record review and confirmed through an interview with the technical consultant (TC), the TC failed to assess the competency of all testing personnel (TP) through testing previously analyzed specimens, internal blind testing samples or external proficiency testing (PT) samples in the specialty of Microbiology. Findings include: 1. Record review on 10/4/2024 of the laboratory's 2023 and 2024 American Proficiency Institute Microbiology PT attestation sheets revealed 1 of 2 TP (TP2) did not participate in testing external PT samples in the specialty of Microbiology. 2. Record review on 10/4/2024 of the laboratory's PT policy revealed, "It is important that each testing person actively participate in the PT testing program." 3. Record review on 10/4/2024 of the laboratory's 2023 and 2024 competency assessment records for TP2 revealed: a. The Section titled, 'Has performed proficiency samples' was checked off as being performed. b. The competency records were signed by the TC. c. The form did not contain any information concerning previously analyzed or internal blind samples. 4. Staff interview on 10/4/2024 at 11:00 AM with the TC confirmed TP2 did not perform PT or test a previously analyzed or blind sample in 2023 and 2024 in the specialty of Microbiology. 5. The laboratory performs 3,000 tests annually in the specialty of Microbiology. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 7, 2021

Survey Type: Standard

Survey Event ID: 9Q5G11

Deficiency Tags: D0000 D2123 D2123 D5429 D5429

Summary:

Summary Statement of Deficiencies D0000 A CLIA recertification survey was conducted for the laboratory pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. D2123 HEMATOLOGY CFR(s): 493.851(c) Failure to participate in a testing event is unsatisfactory performance and results in a score of 0 for the testing event. Consideration may be given to those laboratories failing to participate in a testing event only if-- (1) Patient testing was suspended during the time frame allotted for testing and reporting proficiency testing results; (2) The laboratory notifies the inspecting agency and the proficiency testing program within the time frame for submitting proficiency testing results of the suspension of patient testing and the circumstances associated with failure to perform tests on proficiency testing samples; and (3) The laboratory participated in the previous two proficiency testing events. This STANDARD is not met as evidenced by: . Based on record review and interview with the Technical Consultant (TC) on 9/7/21, the laboratory failed to participate in American Proficiency Institute (API) Proficiency Testing (PT) as evidenced by the following: The surveyor reviewed PT records for calendar years 2019, 2020, and 2021 on 9/7/21. The review revealed a 0% score for the Hematology specialty in first event in 2020 and the second event in 2021. The TC interviewed on 9/7/21 at 11:30 AM confirmed that the laboratory failed to participate in PT for the first event in 2020 and second event in 2021. . D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- must perform and document maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: . Based on lack of record review and interview with the TC on 9/7/21, the laboratory failed to document maintenance of analyzers defined by the manufacturer and with at least the frequency specified by the manufacturer as evidenced by the following: The surveyor asked to review maintenance records required by the manufacturer for the Medonic Hematology analyzer for 2019, 2020, and 2021. The TC stated that the laboratory implemented the maintenance log for the analyzer about a week prior and that the laboratory was performing the necessary daily, monthly, and 6 month maintenance but was not recording it on the maintenance log sheet. The TC interviewed on 9/7/21 at 10:30 AM confirmed that manufacturer required maintenance on the Medonic Hematology analyzer was not documented in 2019, 2020, and 2021. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 29, 2020

Survey Type: Special

Survey Event ID: OU4211

Deficiency Tags: D0000 D2004 D2016 D2130 D0000 D2004 D2016 D2130

Summary:

Summary Statement of Deficiencies D0000 Based on evidence of unsuccessful proficiency testing performance for the White Blood Cell Differential analyte, the following Condition level deficiency was deemed to be not met: Condition 42 CFR 493.803 - Proficiency Testing - Successful Participation. . D2004 ENROLLMENT CFR(s): 493.801(a)(3) For each specialty, subspecialty and analyte or test, participate in one approved proficiency testing program or programs, for one year before designating a different program and must notify CMS before any change in designation; This STANDARD is not met as evidenced by: Based on proficiency testing review for calendar years 2019 and 2020 the laboratory failed to participate in one proficiency testing program before designating another program and notifying CMS of the change in designation as evidenced by the following: a) A review of 2019 and 2020 American Proficiency Institute (API) proficiency testing for hematology revealed that the laboratory was enrolled for calendar years 2019 and 2020. A review of CMS report a 0155D -Individual Laboratory Profile (proficiency testing) revealed that the laboratory was also enrolled in Wisconsin Laboratory State of Hygiene (WSLH) for hematology for calendar year 2020. b) There was no notification received by the State Agency or CMS regarding the change in designation of the proficiency testing service. D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on proficiency testing review for calendar years 2019 and 2020 (three testing events), the laboratory failed to successfully participate (achieve a score of 80 percent or more) in the American Proficiency Institute (API) proficiency testing program for the White Blood Cell Differential analyte. Refer to D2123 and D2130. D2130 HEMATOLOGY CFR(s): 493.851(f) Failure to achieve satisfactory performance for the same analyte in two consecutive events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on record review of calendar years 2019 and 2020 American Proficiency Institute (API))proficiency testing results, the laboratory failed to attain a testing event score of at least 80 percent for all hematology analytes as evidenced by the following testing event scores: a) White Blood Cell Differential Analyte: 1. 2019 MLE testing event 2 - score of 40 %. 2. 2019 MLE testing event 3 - score of 0 % -(failure to participate). b) The scores were confirmed by email correspondence with the technical consultant on 9/16/20. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - December 16, 2019

Survey Type: Special

Survey Event ID: L3FY11

Deficiency Tags: D0000 D2016 D2020 D2026 D0000 D2016 D2020 D2026 D2028 D2028

Summary:

Summary Statement of Deficiencies D0000 A CLIA paper desk review of proficiency testing was conducted for the the Raynham- Taunton Pediatrics laboratory pursuant to the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and CLIA regulations at 42 CFR 493. Based on evidence of unsuccessful proficiency testing performance for the Bacteriology subspeciaty, the following Condition level deficiency was deemed to be not met: Condition 42 CFR 493.803 - Proficiency Testing - Successful Participation. . D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on proficiency testing review for calendar year 2019 (three testing events), of the Wisconsin State Laboratory of Hygiene (WSLH)proficiency testing results, the Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- laboratory failed to successfully participate (achieve a score of 80 percent or more) in a proficiency testing program for the Bacteriology subspecialty as evidenced by the following: The laboratory achieved a score for the Bacteriology subspecialty of sixty (60) percent for the second and third testing events of 2019 resulting in unsuccessful performance for the analyte. Refer to D2020 and D2028. . D2020 BACTERIOLOGY CFR(s): 493.823(a) Failure to attain an overall testing event score of at least 80 percent is unsatisfactory performance. This STANDARD is not met as evidenced by: Based on proficiency testing review for calendar year 2019 (three testing events) the laboratory failed to attain an overall score of at least 80 percent for each Bacteriology subspecialty testing event. The laboratory achieved an overall testing event score of sixty (60) percent for the second and third testing events of 2019 resulting in unsatisfactory performance for each testing event. . D2026 BACTERIOLOGY CFR(s): 493.823(d) (1) For any unsatisfactory testing event for reasons other than a failure to participate, the laboratory must undertake appropriate training and employ the technical assistance necessary to correct problems associated with a proficiency testing failure. (2) Remedial action must be taken and documented, and the documentation must be maintained by the laboratory for two years from the date of participation in the proficiency testing event. This STANDARD is not met as evidenced by: Based on proficiency testing review for calendar year 2019 (three testing events), the laboratory failed to ensure that remedial action was taken and documented in response to proficiency testing failures as evidenced by the following: The laboratory received an overall unacceptable testing score for the Bacteriology subspecialty of sixty (60) percent for the second testing event of 2019. The laboratory subsequently received an overall unacceptable testing score for the the Bacteriology subspecialty of sixty (60) percent for the third testing event of 2019. Based on the second unacceptable testing event scores there was no assurance that appropriate training had been undertaken and technical assistance employed to correct the problems associated with proficiency testing failures in the subspecialty area of Bacteriology. . D2028 BACTERIOLOGY CFR(s): 493.823(e) Failure to achieve an overall testing event score of satisfactory performance for two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on proficiency testing review for calendar year 2019 (three testing events), the -- 2 of 3 -- laboratory failed to achieve satisfactory performance for the subspecialty of Bacteriology. The laboratory achieved an overall testing event score of sixty (60) percent for the second and third testing events of 2019 resulting in unsuccessful performance for the subspecialty of Bacteriology Refer to D2016. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access